The Amplicor HCV Monitor test and the Quantiplex HCV RNA 2.0 (bDNA) assay are two commercially available assays for the quantification of hepatitis C virus (HCV) RNA in clinical samples. A direct comparison of the two assays was carried out using sera frozen previously from patients known to be chro
Usefulness of hepatitis C virus RNA counts by second generation HCV bDNA-probe in chronic hepatitis C based on the HCV genotype
✍ Scribed by Mariko Kobayashi; Hiromitsu Kumada; Yasuji Arase; Kazuaki Chayama; Masahiro Kobayashi; Akihito Tsubota; Isao Koida; Satoshi Saitoh; Yosiyuki Suzuki; Naoya Murashima; Kenji Ikeda; Yukiko Miyano; Kaori Mizoshita; Marie Matsuda; Hiromi Koike; Michie Hashimoto
- Publisher
- Springer Japan
- Year
- 1998
- Tongue
- English
- Weight
- 312 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4
WHO International Standards for nucleic acid tests are used widely to compare the different assays used in HCV RNA quantitation. The aim of the study was to assess the impact of the international unit standard for measuring HCV RNA in the management of patients with chronic hepatitis C virus (HCV) i